2016
|
Invention
|
Methods for making and using an immunoconjugate for the treatment of cancer. The present inventio... |
|
Invention
|
Her2 immunotoxins and methods of using the same. The present invention relates to methods for pre... |
|
Invention
|
Deimmunized linker and methods of use. The present disclosure is directed to novel deimmunized fu... |
|
Invention
|
Methods of treatment for epcam positive bladder cancer. The present disclosure provides compositi... |
|
Invention
|
Dosing strategies for targeting epcam positive bladder cancer. The present disclosure provides me... |
2015
|
Invention
|
Tumor specific antibody.
The present invention provides the amino acid and nucleic acid sequence... |
2014
|
Invention
|
Cancer-associated antigen related applications.
The present invention provides a novel cancer-as... |
|
Invention
|
Anti-epcam antibodies and methods of use. The present disclosure is related to compositions of an... |
|
Invention
|
Compositions and methods for detection and treatment of hepatocellular carcinoma.
Disclosed here... |
|
Invention
|
Compositions and methods for detection and treatment of hepatocellular carcinoma. Disclosed herei... |
2013
|
Invention
|
Antibody conjugates against variant nfkbib and uses thereof. The present application provides the... |
|
Invention
|
Cancer-associated antigen. The present invention provides a novel cancer-associated antigen that ... |
|
Invention
|
Tumor specific antibody. The present invention provides the amino acid and nucleic acid sequences... |
2012
|
Invention
|
Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof.
The present a... |
2011
|
Invention
|
Cancer specific antibody and cell surface proteins. The present invention provides the amino acid... |
2008
|
Invention
|
Antibodies against a cancer-associated epitope of variant nfkbib and uses thereof. The present ap... |
|
Invention
|
Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof. The present ap... |
|
Invention
|
Optimized nucleic acid sequences for the expression of vb4-845. Escherichia coli expression system. |
|
Invention
|
Binding proteins that bind to epcam linked to an effector molecule. E. coli expression system. |
|
Invention
|
Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins. An optimized nu... |
2006
|
Invention
|
Methods for generating and screening fusion protein libraries and uses thereof. The invention pro... |
|
Invention
|
Novel cancer-associated antigen. The present invention provides a novel cancer-associated antigen... |
2005
|
Invention
|
Cancer associated glucose transporter 8 variant. The present invention provides the amino acid an... |
|
Invention
|
Cd44e tumor specific antibody. The present invention provides the amino acid and nucleic acid seq... |
2000
|
G/S
|
Polypeptides for use in the biopharmaceutical industry; biopharmaceutical preparations for immuno... |
1999
|
Invention
|
Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragmen... |
1994
|
Invention
|
Human monoclonal antibodies specific to cell cycle independent glioma surface antigen. The variab... |